Von der zeckenentfernung bis zur immuntherapie: Lyme-Borreliose verhindern, erkennen, behandeln

Translated title of the contribution: Infestation of ticks with Borrelia, and Lyme borreliosis in Germany

C. Rauter, T. Hartung

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations


Currently, borreliosis is the most common tick-borne infectious disease in Europe and the USA. In Europe, three species of Borrelia are known to be pathogenic for humans, each of which apparently give rise to different clinical symptoms. Diagnosis is based in particular on the clinical presentation and history of exposure, and, as a rule, is confirmed by serological methods. It must, however, be remembered that the humoral immune response may appear relatively late, so at an early stage, patients are still serologically negative. Depending on the stage involved, oral or peroral antibiotic treatment is applied - however, eradication of the pathogen is unsuccessful in some cases. In future, adjuvant immunotherapy might close the therapeutic gap.

Translated title of the contributionInfestation of ticks with Borrelia, and Lyme borreliosis in Germany
Original languageGerman
Pages (from-to)36-38
Number of pages3
JournalMMW-Fortschritte der Medizin
Issue number15
StatePublished - Apr 10 2003
Externally publishedYes


  • Borrelia
  • Diagnosis
  • Epidemiology
  • Lyme borreliosis
  • Prevention
  • Ticks

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Infestation of ticks with Borrelia, and Lyme borreliosis in Germany: Lyme-Borreliose verhindern, erkennen, behandeln'. Together they form a unique fingerprint.

Cite this